Breaking News

PL BioScience Names Summit Pharmaceuticals as Exclusive Japan Distributor

Summit Pharmaceuticals to distribute PL BioScience’s ELAREM Ultimate-FD PLUS and broader ELAREM portfolio for clinical applications.

Author Image

By: Charlie Sternberg

Associate Editor

PL BioScience GmbH, a German manufacturer of Human Platelet Lysate used in cell therapy and regenerative medicine, has signed an exclusive distribution agreement with Summit Pharmaceuticals International Corp. for the Japanese market. Under the arrangement, Summit Pharmaceuticals will distribute PL BioScience’s ELAREM Ultimate-FD PLUS, a GMP‑grade platelet lysate product, along with the company’s broader ELAREM portfolio for clinical applications. The companies said the partnership is intende...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters